These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6321609)

  • 1. Entry of four cephalosporins into the ovine lung.
    Cohen SH; Hoeprich PD; Demling R; Gunther R; Merry JM; Franti CE; Miner DJ
    J Infect Dis; 1984 Feb; 149(2):264-70. PubMed ID: 6321609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusibility of the newer cephalosporins into human interstitial fluids.
    Tan JS; Salstrom SJ; File TM
    Am J Med; 1984 Oct; 77(4C):33-6. PubMed ID: 6093516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovine pulmonary transit of tetracycline and minocycline.
    Cohen SH; Hoeprich PD; Gunther R; Merry JM; Franti CE
    Diagn Microbiol Infect Dis; 1987 Jan; 6(1):53-8. PubMed ID: 3802746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic properties of the newer cephalosporins. A valid basis for drug selection?
    Noble JT; Barza M
    Drugs; 1985 Sep; 30(3):175-81. PubMed ID: 3899596
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of cefaronide, ceftriaxone and cefoperazone in sheep.
    Guerrini VH; Filippich LJ; Cao GR; English PB; Bourne DW
    J Vet Pharmacol Ther; 1985 Jun; 8(2):120-7. PubMed ID: 4020943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Entry of five antifungal agents into the ovine lung.
    Hoeprich PD; Merry JM; Gunther R; Franti CE
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1234-7. PubMed ID: 3631944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the new cephalosporins.
    Brogard JM; Comte F
    Antibiot Chemother (1971); 1982; 31():145-210. PubMed ID: 6277241
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.
    Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC
    Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime.
    Wise R; Andrews JM
    Eur J Clin Microbiol; 1983 Oct; 2(5):505-8. PubMed ID: 6315427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.
    Schaad UB; McCracken GH; Loock CA; Thomas ML
    J Infect Dis; 1981 Feb; 143(2):156-63. PubMed ID: 6260870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
    Kemmerich B; Lode H; Belmega G; Jendroschek T; Borner K; Koeppe P
    Antimicrob Agents Chemother; 1983 Mar; 23(3):429-34. PubMed ID: 6303213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
    Livermore DM; Williams RJ; Williams JD
    J Antimicrob Chemother; 1981 Oct; 8(4):323-31. PubMed ID: 6271726
    [No Abstract]   [Full Text] [Related]  

  • 13. Affinity of cefmenoxime for beta-lactamases: an analysis.
    Labia R; Morand A; Verchere-Beaur C; Bryskier A
    Am J Med; 1984 Dec; 77(6A):25-7. PubMed ID: 6097119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of moxalactam and cefazolin into bone following simultaneous bolus or infusion.
    Polk R; Hume A; Kline BJ; Cardea J
    Clin Orthop Relat Res; 1983; (177):216-21. PubMed ID: 6222858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
    Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM
    Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the in vitro activity of new cephalosporins on strains of Neisseria gonorrhoeae of the Toulouse region.
    Prère MF; Lefèvre JC; Lareng MB
    Chemotherapy; 1981; 27 Suppl 1():15-8. PubMed ID: 6265158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefazolin and moxalactam pharmacokinetics after simultaneous intravenous infusion.
    Polk RE; Kline BJ; Markowitz SM
    Antimicrob Agents Chemother; 1981 Nov; 20(5):576-9. PubMed ID: 6459759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.